1 January 2016 in The Journal of Immunology
Nonalcoholic fatty liver disease is increasing in prevalence. It can be subdivided into nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). Five to twenty percent of cases progress from NAFL to NASH. Increased hepatic Th17 cells and IL-17 expression were observed in NASH mice and patients, respectively. We analyzed CD4+ effector T cells and regulatory T cells (Tregs) from peripheral blood and livers of NAFL and NASH patients. A total of 51 NAFL patients, 30 NASH patients, 31 nonalcoholic fatty liver disease patients (without histology), and 43 healthy controls were included. FACS analysis was performed on PBMCs and intrahepatic lymphocytes. Compared with healthy controls, a lower frequency of resting Tregs (rTregs; CD4+CD45RA+CD25++) and higher frequencies of IFN-γ+ and/or IL-4+ cells were detected among CD4+ T cells of peripheral blood in NASH, and to a lesser degree in NAFL. In hepatic tissue, NAFL to NASH progression was marked by an increase in IL-17+ cells among intrahepatic CD4+ T cells. To define immunological parameters in peripheral blood to distinguish NAFL from NASH, we calculated different ratios. Th17/rTreg and Th2/rTreg ratios were significantly increased in NASH versus NAFL. The relevance of our findings for NASH pathogenesis was highlighted by the normalization of all of the changes 1 y after bariatric surgery. In conclusion, our data indicate that NAFL patients show changes in their immune cell profile compared with healthy controls. NAFL to NASH progression is marked by an increased frequency of IL-17+ cells among intrahepatic CD4+ T cells and higher Th17/rTreg and Th2/rTreg ratios in peripheral blood.
1 June 2019 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
14 February 2012 in The World Journal of Biological Psychiatry
OBJECTIVES: Although Alzheimer's disease (AD) is the most common form of dementia in the elderly, its aetiology remains mostly unknown. A potential pathophysiological mechanism for AD arises from the knowledge that insulin is also synthesized independently in the central nervous system and is involved in the regulation of memory formation. AD may represent a brain-specific form of insulin resistance.\ud METHODS: We used immunohistochemistry to investigate the numbers of cells expressing insulin receptor β-subunit (IRβ) and phosphorylated PPARγ (PPARγ(p)) in human post-mortem tissue from patients with AD; AD combined with type 2 diabetes mellitus (T2DM); just T2DM , and from aged-matched controls. These numbers were evaluated in frontal cortex and in dorsal/ventral parts of the hippocampus.\ud RESULTS: We observed significantly lower numbers of IRβ positive cells in AD cases compared to all other groups in all investigated brain regions. Also significantly more PPARγ(p) positive cells occurred in each patient group compared to control.\ud CONCLUSIONS: T2DM and AD may not be directly linked, but may share common histological features including lower numbers of IRβ positive cells and higher numbers of PPARγ(p) positive cells in all investigated brain regions. These observations may at least partially explain the increased frequency of AD in elderly diabetic patients
31 December 2013 in Current Alzheimer Research
Oxidative stress is implicated in the pathogenesis of neurodegenerative diseases, including sporadic Alzheimer´s disease (AD). Mitochondrial DNA (mtDNA) deletions are markers of oxidative damage and increase with age. To unravel the impact of mtDNA damage on AD development, we analyzed mtDNA deletion levels in diverse neuronal cell types of four brain regions (hippocampal CA1 and CA2 regions, nucleus tractus spinalis nervi trigemini, and the cerebellum) that exhibit differing levels of vulnerability to AD related changes at progressive Braak stages compared with age-matched controls. Neurons from these four brain regions were collected using laser microdissection, and analyzed using quantitative polymerase chain reaction (qPCR). Although, no correlation between mtDNA deletion levels and AD progression were found, the data revealed regional and cell type specific selective vulnerability towards mtDNA deletion levels. In conclusion, unexpected results were obtained as granule cells from the cerebellum and neurons from the nucleus tractus spinalis nervi trigemini of the brain stem displayed significant higher mtDNA deletion levels than pyramidal cells from hippocampal CA1 and CA2 region in age and AD.
11 August 2014 in Zeitschrift für Gastroenterologie
Background: The prevalence of non-alcoholic fatty liver disease (NAFLD) ranges between 20 – 35% in Europe. In 5 to 20% there is a progression from non-alcoholic fatty liver (NAFL) to a non-alcoholic steatohepatitis (NASH) but it is still not understood why some people develop NASH. The current hypothesis about the pathogenesis is a two hit theory. The “first hit” causes a steatosis and the “second hit” in form of bacterial translocation leads to an inflammation and the development of NASH. Hepatic Th17 cell infiltration was observed in a NASH mouse model and higher IL-17 and IL-21 gene expression in human liver of NASH patients. We hypothesized that the phenotype of peripheral CD4+ T cells might be predictive for the degree and quality of hepatic T cell infiltration and histopathology. Aims: Characterization of CD4+ regulatory T cells (Tregs) and conventional CD4+ T cells in peripheral blood and hepatic tissue in patients with NAFL and NASH. Methods: 50 patients with histology-proven NAFL or NASH and 44 healthy controls (HC) were included in this study. PBMCs of peripheral blood and hepatic tissue were characterized by multi-colour FACS analysis. CD4+ T cells were stimulated with PMA and ionomycin for intracellular detection of cytokine production (IL-17, IL-4, INF-g, IL-21). Results: Patients were older and had a higher BMI in comparison to HC. In patients with NAFL and NASH a lower frequency of resting Tregs (CD4+CD45RA+CD25++) was observed in peripheral blood. We found changes in effector CD4+ T cells with higher frequencies of IFN-g+, IL-21+ and IL4+ cells among CD4+ T cells of the peripheral blood of patients. In hepatic tissue, higher frequency of IL17+, IFN-g+, IL21+ and IL4+ cells were measured among CD4+ T cells than in the peripheral blood. CD4+ T cells in peripheral blood and hepatic tissue contained higher frequencies of HLA-DR+, i.e. activated cells. Conclusions: The peripheral blood and hepatic tissue of patients with NAFLD contained higher frequencies of activated effector cells among CD4+ T cells. NAFL patients show a “prehepatitic” immune cell profile very similar to that seen in NASH. Our data suggest that interfering with the effector CD4+ T cell response might prevent progression from NAFL to NASH.
14 September 2015 in Zeitschrift für Gastroenterologie
Background: The prevalence of non-alcoholic fatty liver disease (NAFLD) is rising in the last decades and non-alcoholic fatty liver (NAFL) as well as non-alcoholic steatohepatitis (NASH) are now endemic in Western countries. The current hypothesis about the pathogenesis is a two hit theory, i.e. first steatosis due to e.g. metabolic syndrome and then inflammation of the fatty liver due to bacterial translocation from the gut. Thus, 5 to 20% of NAFL patients progress to NASH. It is still not well understood why some patients develop NASH and others remain with NAFL. Higher frequencies of Th17 cells were observed in livers of a NASH mouse model and higher IL-17 and IL-21 gene expression was described in human livers of NASH patients. We hypothesized that the phenotype of peripheral CD4+ T cells might be predictive for the degree and quality of hepatic T cell infiltration and histopathology. Aims: To analyse differences in the hepatic and peripheral immune phenotype in patients with NAFL and NAFLD with a focus on conventional CD4+ effector T cell subsets and CD4+ regulatory T cells (Tregs). Methods: 40 patients with NAFL, 17 patients with NASH and 44 healthy controls (HC) were included in this study. Multi-colour FACS analysis was performed of PBMCs and intrahepatic lymphocytes. CD4+ T cells were stimulated with PMA and ionomycin for intracellular detection of cytokine production (IL-17, IL-4, INF-g, IL-21). Results: Patients were older, had a higher BMI and a higher CK-18 serum level in comparison to HC. In peripheral blood, NAFLD and NASH patients had higher frequencies of HLA-DR+, i.e. activated, effector memory, IFN-g+, IL-17+, IL-21+ and IL-4+ cells and lower frequencies of CD45RA+ CD25+ resting Tregs among CD4+ T cells than HC. Closer analysis of Th1 cells among PBMCs revealed that T-bet expression was lower among CXCR3+ cells of NASH than NAFLD patients. The CD4+ T cells infiltrating the liver of NAFLD and NASH patients consisted to more than 80% of CXCR3+ effector memory cells with more than 50% recently activated, i.e. HLA-DR+, cells and frequencies of cells producing the named cytokines elevated at least five- to ten-fold in comparison to PBMCs. Higher frequencies of IL-17+ cells among intrahepatic CD4+ T cells and a higher Th17/resting Treg ratio distinguished NAFLD from NASH patients. Conclusions: Our data indicate that NAFL patients show a “prehepatitic” immune cell profile very similar to that seen in NASH. The progression from NAFLD to NASH is marked by increased frequencies of IL-17+ cells among intrahepatic CD4+ T cells and a higher Th17/Treg ratio. In the peripheral blood, NASH patients showed a lower expression of T-bet among CXCR3+ CD4+ T cells than NAFLD patients.